Business Description
Pulike Biological Engineering Inc
ISIN : CNE1000025N0
Share Class Description:
SHSE:603566: Class ACompare
Compare
Traded in other countries / regions
603566.China IPO Date
2015-05-18Description
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 276.05 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 306.89 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.36 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.9 | |||||
| 3-Year EBITDA Growth Rate | -5.6 | |||||
| 3-Year EPS without NRI Growth Rate | -2.9 | |||||
| 3-Year Book Growth Rate | 13.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 13.94 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.47 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.91 | |||||
| 9-Day RSI | 31.03 | |||||
| 14-Day RSI | 39.39 | |||||
| 6-1 Month Momentum % | -8.45 | |||||
| 12-1 Month Momentum % | -41.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.93 | |||||
| Quick Ratio | 2.51 | |||||
| Cash Ratio | 1.38 | |||||
| Days Inventory | 161.09 | |||||
| Days Sales Outstanding | 140.03 | |||||
| Days Payable | 119.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.07 | |||||
| Dividend Payout Ratio | 2.07 | |||||
| 3-Year Dividend Growth Rate | 48.1 | |||||
| Forward Dividend Yield % | 8.06 | |||||
| 5-Year Yield-on-Cost % | 6.57 | |||||
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | 3.34 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.95 | |||||
| Operating Margin % | 11.7 | |||||
| Net Margin % | 9.36 | |||||
| FCF Margin % | 7.81 | |||||
| ROE % | 3.78 | |||||
| ROA % | 3.18 | |||||
| ROIC % | 5.47 | |||||
| ROC (Joel Greenblatt) % | 8.12 | |||||
| ROCE % | 3.97 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 44.55 | |||||
| Forward PE Ratio | 23.71 | |||||
| PE Ratio without NRI | 38.22 | |||||
| Shiller PE Ratio | 23.49 | |||||
| PEG Ratio | 4.5 | |||||
| PS Ratio | 4.11 | |||||
| PB Ratio | 1.69 | |||||
| Price-to-Tangible-Book | 1.9 | |||||
| Price-to-Free-Cash-Flow | 52.55 | |||||
| Price-to-Operating-Cash-Flow | 20.34 | |||||
| EV-to-EBIT | 35.17 | |||||
| EV-to-EBITDA | 35.17 | |||||
| EV-to-Revenue | 3.51 | |||||
| EV-to-FCF | 47.82 | |||||
| Price-to-Projected-FCF | 2.09 | |||||
| Price-to-Graham-Number | 1.86 | |||||
| Price-to-Net-Current-Asset-Value | 6.12 | |||||
| Price-to-Net-Cash | 40.45 | |||||
| Earnings Yield (Greenblatt) % | 2.85 | |||||
| FCF Yield % | 1.84 | |||||
| Forward Rate of Return (Yacktman) % | -4.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulike Biological Engineering Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,085.89 | ||
| EPS (TTM) (Â¥) | 0.29 | ||
| Beta | 1.25 | ||
| Volatility % | 43.76 | ||
| 14-Day RSI | 39.39 | ||
| 14-Day ATR (Â¥) | 0.455723 | ||
| 20-Day SMA (Â¥) | 13.6295 | ||
| 12-1 Month Momentum % | -41.78 | ||
| 52-Week Range (Â¥) | 10.8 - 25 | ||
| Shares Outstanding (Mil) | 346.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulike Biological Engineering Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulike Biological Engineering Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pulike Biological Engineering Inc Frequently Asked Questions
What is Pulike Biological Engineering Inc(SHSE:603566)'s stock price today?
The current price of SHSE:603566 is ¥13.35. The 52 week high of SHSE:603566 is ¥25.00 and 52 week low is ¥10.80.
When is next earnings date of Pulike Biological Engineering Inc(SHSE:603566)?
The next earnings date of Pulike Biological Engineering Inc(SHSE:603566) is .
Does Pulike Biological Engineering Inc(SHSE:603566) pay dividends? If so, how much?
The Dividend Yield %  of Pulike Biological Engineering Inc(SHSE:603566) is 3.07% (As of Today), Highest Dividend Payout Ratio of Pulike Biological Engineering Inc(SHSE:603566) was 2.07. The lowest was 0.34. And the median was 0.79. The  Forward Dividend Yield % of Pulike Biological Engineering Inc(SHSE:603566) is 8.06%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers